Shorla Pharma in a $35M series B with Kurma life science partners.
09 September 2023
09 September 2023
Total investments received (USD): 43.3m
Round value (USD): 35m
Company: Shorla Pharma
Industry:
Health services
Pharma
Related deals
Asgard Therapeutics in a €30 million Series A co-led by RV Invest and Johnson & Johnson's JJDC, w/ Novo Holdings, Boehringer Ingelheim and Industrifonden
Investments
05 March 2024
Relation Therapeutics raises $35 million seed extension from NVentures, DCVC, Deerfield Management, Khosla Ventures, ARK Invest and Magnetic Ventures.
Investments
04 March 2024
Phagenesis raises $42m series D led by EQT Life Sciences and Sectoral Asset Management, w/ British Patient Capital, Northern Gritstone and Aphelion
Investments
27 February 2024
Halo Technologies raised a $20 million Series A round led by Volition Capital
Investments
20 February 2024
Orbis Medicines in a €26 million seed financing round with Novo Holdings and Forbion.
Investments
12 February 2024
Belgium
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Italy
Portugal
Spain